2024
M145 Assessing Provider Readiness to Implement Pre-Exposure Prophylaxis for HIV Prevention and Medications for Opioid Use Disorder Among People who Inject Drugs
Pickering E, Sung M, Bailey G, Buchelli M, Davidson D, Jenkins M, John B, Kolakowski J, Maier L, Porter E, Perez O, Rash C, Edelman E, Viera A. M145 Assessing Provider Readiness to Implement Pre-Exposure Prophylaxis for HIV Prevention and Medications for Opioid Use Disorder Among People who Inject Drugs. Drug And Alcohol Dependence 2024, 260: 110425. DOI: 10.1016/j.drugalcdep.2023.110425.Peer-Reviewed Original Research
2022
Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs
Sung M, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, Bailey G, Buchanan A, Buchelli M, Jenkins M, John B, Kolakowski J, Lame A, Murphy S, Porter E, Simone L, Paris M, Rash C, Edelman E. Contingency management and pre-exposure prophylaxis adherence support services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemporary Clinical Trials 2022, 125: 107037. PMID: 36460267, PMCID: PMC9918697, DOI: 10.1016/j.cct.2022.107037.Peer-Reviewed Original ResearchConceptsAdherence support servicesHIV risk reductionPrEP adherenceContingency managementHybrid type 1 effectiveness-implementation trialHIV pre-exposure prophylaxisEffectiveness-implementation studyPre-exposure prophylaxisEffectiveness-implementation trialOpioid use disorderStrengths-based case managementRisk reductionSupport servicesCommunity-based programsPrEP initiationPrimary outcomeWeek 12Clinical trialsHIV preventionUse disordersCM sessionsCase managementBlood spotsPWIDStudy design
2019
Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers
Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham CO, Ogbuagu O, Patel VV, Phillips KA, Tetrault JM, Shah M, Blackstock O. Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers. Preventive Medicine Reports 2019, 17: 101012. PMID: 31890474, PMCID: PMC6926349, DOI: 10.1016/j.pmedr.2019.101012.Peer-Reviewed Original ResearchPrimary care physiciansPre-exposure prophylaxisPrEP implementationPrEP prescribingPrimary careHIV pre-exposure prophylaxisMost primary care physiciansSite specialistPrimary care providersDirect patient careGuidelines/protocolsPrEP deliveryCare physiciansHIV preventionGeneral internistsCare providersClinical carePatient careCarePrEPProphylaxisNational professional organizationsImplementation barriersFuture studiesParticipants